JCR Pharmaceuticals Company Ltd (PK) (JCRRF)
USOTC
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Return on Assets (%) | 5.195 | 8.21 | 9.183 | 5.932 | 11.339 | 16.975 | 3.928 | 5.586 |
Return on Equity (%) | 6.819 | 11.141 | 12.722 | 8.441 | 19.377 | 32.365 | 7.289 | 10.115 |
Return on Invested Capital (%) | 7.312 | 11.393 | 13.743 | 8.255 | 18.465 | 34.639 | 7.219 | 9.148 |
Operating Margin (%) | 13.944 | 19.044 | 21.369 | 13.898 | 28.901 | 38.074 | 15.887 | 17.098 |
Net Profit Margin (%) | 10.302 | 14.907 | 16.041 | 10.807 | 22.908 | 28.399 | 10.983 | 12.846 |
Book Value Per Share | 848.752 | 845.599 | 948.862 | 996.761 | 272.389 | 371.119 | 376 | 408.525 |
Earnings Per Share | 57.466 | 94.689 | 114.583 | 82.598 | 53.144 | 111.862 | 29.086 | 42.464 |
Cash Per Share | 169.93 | 150.978 | 241.688 | 338.443 | 202.489 | 236.98 | 102.386 | 144.626 |
Working Capital Per Share | 481.408 | 500.339 | 576.275 | 552.341 | 150.494 | 155.252 | 92.84 | 211.634 |
Operating Profit Per Share | 425.663 | 488.804 | 553.205 | 564.863 | 186.335 | 328.224 | 211.696 | 265.626 |
EBIT Per Share | 76.886 | 120.134 | 151.996 | 105.546 | 66.723 | 149.623 | 41.732 | 55.858 |
EBITDA Per Share | 76.886 | 120.134 | 151.996 | 105.546 | 66.723 | 149.623 | 41.732 | 55.858 |
Free Cash Flow Per Share | 82.136 | 107.581 | 129.326 | 218.062 | 108.053 | 205.304 | 98.985 | 53.259 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 32,42M | 32,42M | 32,42M | 32,42M | 129,69M | 129,69M | 129,69M | 129,69M |
Capitalisation boursière | 565,57M |
Ratio cours/bénéfice | 0,1 |
Ratio prix/ventes | 0,01 |
Ratio prix/liquidités | 0,03 |
Ratio prix/valeur comptable | 0,01 |
Rendement de dividende | 43 763,68% |
Actions en circulation | 123,76M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | -26,29% |
Plus haut sur 52 semaines | 6,20 |
Plus bas sur 52 semaines | 4,3004 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales